News
Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...
Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.
Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...
11hon MSN
Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...
A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...
Explore more
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...
Drugmaker Eli Lilly and Company has hired Sandy Rodriguez as SVP and chief communications officer, effective on June 9. Rodriguez will report to Jennifer Oleksiw, SVP and global chief customer officer ...
Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.
Five distinguished alumni have earned recognition for leading by example, scaling corporate peaks on their own terms and ...
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results